comparemela.com

Latest Breaking News On - Breaking science - Page 2 : comparemela.com

GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 ()

GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 () | aktiencheck.de

United statesSwitzerland generalMarkus schlaichArthurc corcoranAndrewc weissInternational society of hypertensionEuropean societyIdorsia pharmaceuticals ltdHead of investor relations corporate communicationsSwiss exchangeIdorsia ltdAmerican heart associationEuropean society of hypertensionHypertension councilEuropean society of cardiologyEuropean meeting

GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202

^Allschwil, Switzerland - June 23, 2023 Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia's investigational dual endothelin receptor antagonist evaluating the treatment of patients with resistant hypertension, will be presented as an oral presentation by Prof. M.

Switzerland generalUnited statesAndrewc weissArthurc corcoranMarkus schlaichHypertension councilIdorsia pharmaceuticals ltdSwiss exchangeAmerican heart associationEuropean societyEuropean society of hypertensionIdorsia ltdEuropean society of cardiologyInternational society of hypertensionHead of investor relations corporate communicationsEuropean meeting

newratings de

newratings de
newratings.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newratings.de Daily Mail and Mail on Sunday newspapers.

Switzerland generalUnited statesIhre freundeAndrewc weissArthurc corcoranMarkus schlaichIdorsia ltdAmerican heart associationEuropean society of hypertensionSwiss exchangeInternational society of hypertensionEuropean society of cardiologyEuropean societyHypertension councilIdorsia pharmaceuticals ltdHead of investor relations corporate communications

Börse Express - GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202

^Allschwil, Switzerland - June 23, 2023

United statesSwitzerland generalWirtschaftsnachrichten gmbMarkus schlaichArthurc corcoranAndrewc weissEuropean society of hypertensionInternational society of hypertensionHead of investor relations corporate communicationsEuropean societySwiss exchangeIdorsia ltdIdorsia pharmaceuticals ltdAmerican heart associationEuropean society of cardiologyHypertension council

HRS23 Announces Late-breaking Clinical Trials and Science Sessions

Heart Rhythm 2023, the society's 44th annual meeting, takes place May 19-21, in New Orleans

Collaborative groupEfficacy of low energy multiChamber leadless cardiac pacemaker systemCollaborative study groupA prospective left bundle branch pacing studyHeart rhythm societyEnergy multiHeart rhythmBreaking randomized clinical trialsBreaking clinical innovationsBreaking clinical trial updatesBreaking scienceWeight lossAtrial fibrillation ablation outcomeLiraglutide effectAtrial fibrillation

vimarsana © 2020. All Rights Reserved.